MAI Capital Management trimmed its holdings in Albemarle Co. (NYSE:ALB – Free Report) by 90.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,002 shares of the specialty chemicals company’s stock after selling 63,351 shares during the quarter. MAI Capital Management’s holdings in Albemarle were worth $663,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of ALB. First Community Trust NA acquired a new stake in shares of Albemarle in the second quarter valued at approximately $25,000. CVA Family Office LLC boosted its holdings in shares of Albemarle by 610.0% in the second quarter. CVA Family Office LLC now owns 284 shares of the specialty chemicals company’s stock valued at $27,000 after acquiring an additional 244 shares during the period. Eastern Bank acquired a new stake in shares of Albemarle in the third quarter valued at approximately $31,000. Cromwell Holdings LLC raised its stake in shares of Albemarle by 61.9% during the third quarter. Cromwell Holdings LLC now owns 387 shares of the specialty chemicals company’s stock worth $37,000 after purchasing an additional 148 shares during the last quarter. Finally, ORG Partners LLC raised its stake in shares of Albemarle by 2,142.1% during the second quarter. ORG Partners LLC now owns 426 shares of the specialty chemicals company’s stock worth $42,000 after purchasing an additional 407 shares during the last quarter. 92.87% of the stock is owned by institutional investors and hedge funds.
Albemarle Stock Down 0.6 %
Shares of NYSE:ALB opened at $108.38 on Friday. The stock’s 50-day moving average price is $97.82 and its two-hundred day moving average price is $99.46. The company has a current ratio of 2.44, a quick ratio of 1.58 and a debt-to-equity ratio of 0.43. Albemarle Co. has a 12-month low of $71.97 and a 12-month high of $153.54. The firm has a market cap of $12.74 billion, a price-to-earnings ratio of -6.47 and a beta of 1.55.
Albemarle Announces Dividend
Analyst Ratings Changes
Several research firms have recently commented on ALB. Piper Sandler cut their price target on Albemarle from $95.00 to $90.00 and set an “underweight” rating for the company in a research note on Thursday, August 8th. KeyCorp cut their price target on Albemarle from $132.00 to $127.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Mizuho cut their price target on Albemarle from $128.00 to $103.00 in a research note on Wednesday, July 31st. Berenberg Bank cut Albemarle from a “buy” rating to a “hold” rating and cut their price target for the stock from $160.00 to $83.00 in a research note on Wednesday, July 31st. Finally, Oppenheimer cut their price objective on Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, Albemarle has an average rating of “Hold” and an average price target of $114.47.
Read Our Latest Stock Analysis on Albemarle
Albemarle Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Featured Articles
- Five stocks we like better than Albemarle
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Tesla Investors Continue to Profit From the Trump Trade
- There Are Different Types of Stock To Invest In
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What to Know About Investing in Penny Stocks
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.